Retrospective evaluation of bone marrow cell morphology in a cohort of patients with isolated idic(20q-) karyotypic abnormalities
- 49 Downloads
Isochromosome 20q- (i(20q-)), as a rare reproducible chromosomal anomaly formed on the basis of 20q-, has not been commonly reported. Due to the rarity of this karyotypic anomaly, the bone marrow morphological characteristics of the patients with i(20q-) have not been clarified until now. In this study, the bone marrow cell morphology from MDS patients with isolated i(20q-), isolated 20q-, and normal karyotype was retrospectively compared and statistically analyzed. The results indicated that the isolated i(20q-) was mostly detected in MDS-MLD patients. The frequency and proportion dysplasia of cytoplasmic vacuolization in erythoid cells and small or unusually large size in myeloid cells of isolated i(20q-) MDS patients were significantly higher than those of normal karyotype MDS patients respectively (P < 0.05); the frequency and proportion dysplasia of decreased granules/agranularity in myeloid cells of isolated i(20q-) MDS patients were higher than those of isolated 20q- MDS patients (P < 0.05). The incidence of some specific morphological manifestations, such as deeply lobulated and hyperlobulated megakaryocytes and hypogranular and vacuolized eosinophils, may be an important morphological implication for the anomaly of isolated i(20q-). These morphological features of dysplasia may be helpful in distinguishing MDS with isolated i(20q-) from those with isolated 20q- and normal karyotype.
KeywordsIsolated i(20q-) Isolated 20q- Myelodysplastic syndrome Morphological dysplasia
Dandan Liu, Jinlan Pan, and Chunxiao Wu contributed equally to this paper.
This work was supported in part by the Youth National Natural Science Foundation of China (grant number 81100332) and the Natural Science Foundation of Jiangsu Province (grant number BK20151231).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interests.
- 2.Mitelman F (1991) Catalog of chromosome aberrations in cancer. New YorkGoogle Scholar
- 5.Hasserjian RP, Baumann I, Orazi A et al (2017) Myelodysplastic syndromes: overview. In: Swerdlow SH, Campo E, Harris NL et al (ed) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edn. Lyon, France, pp 98–106Google Scholar
- 6.Shaffer LG, McGowan-Jordan J, Schmid M (2013) ISCN 2013: an international system for human cytogenetics nomenclature. Karger, BaselGoogle Scholar
- 10.Mullier F, Daliphard S, Garand R, Dekeyser M, Cornet Y, Luquet I, Talmant P, Richebourg S, Jamar M, Dogné JM, Chatelain C, Michaux L, Chatelain B (2012) Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or i(20q-): a multicenter study. Ann Hematol 91:203–213CrossRefGoogle Scholar
- 12.Moretti S, Lanza F, Spisani S, Latorraca A, Rigolin GM, Giuliani AL, Castoldi GL, Traniello S (1994) Neutrophils from patients with myelodysplastic syndromes: relationship between impairment of granular contents, complement receptors, functional activities and disease status. Leuk Lymphoma 13:471–477CrossRefGoogle Scholar
- 13.Li T, Xue Y, Wu Y et al (2004) Clinical and cytogenetic features of the myeloid hematological disease with isochromosome 20q. Med J China 84:732–735Google Scholar